VNS Therapy Depression Claim Rejected Over Randomization – CyberonicsPeter Fehrs
Cyberonics, Inc. (http://www.cyberonics.com ) was founded in 1987 to design,develop and market medical devices for the treatment of epilepsy and otherdebilitating disorders using a unique therapy, vagus nerve stimulation. VNStherapy is delivered by the Cyberonics NeuroCybernetic Prosthesis (NCP(...
or eliminate epileptic seizures, as described in U.S. Pat. No. 4,702,254 to Dr. Jacob Zabara, which is hereby incorporated in its entirety herein by reference in this specification. Electrical stimulation of the vagus nerve (hereinafter referred to as vagus nerve stimulation therapy or VNS) ...
(cover story)The article reports on the restructuring initiatives of Cagus Nerve Stimulation (VNS) therapy provider Cyberonics. To enhance its efficiency and reduce operating costs, the company launched a 15% reduction in staff headcount, cutting 90 people from its 600-employee workforce. It has ...
Chloe Taft
The company has enjoyed CMS coverage for the therapy before its reconstruction in February 2007. It notes that VNS Therapy is a device implanted in the chest to send electrical pulses to the brain via the vagus nerve.EBSCO_AspMedical Technology & Devices Week...
Peter FehrsJon Dobson
Priscilla FowlerMalcom PatrickCiteSeerX - Scientific documents that cite the following paper: Anita Carleton and Barbara Merrin (1998), Transition Packages: An Experiment in Expediting the Introduction of Requirements ManagementPeter Fehrs
Cyberonics caps 7-year effort with VNS depression approval.(Vagus Nerve Stimulation therapy system)JOHNSON, HOLLAND
Long, Don